# Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer

> **NCT00003035** · PHASE2 · COMPLETED · sponsor: **Georgetown University** · enrollment: 40 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** paclitaxel
- **DRUG:** tamoxifen citrate
- **PROCEDURE:** surgical procedure
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003035
- **Lead sponsor:** Georgetown University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-03
- **Primary completion:** 2001-06
- **Final completion:** 2001-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003035, "Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*